标题
siRNA: Mechanism of action, challenges, and therapeutic approaches
作者
关键词
siRNA, Nucleic acids-based therapeutics, Nanocarriers, Delivery systems, Gene knockdown
出版物
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 905, Issue -, Pages 174178
出版商
Elsevier BV
发表日期
2021-05-25
DOI
10.1016/j.ejphar.2021.174178
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
- (2020) Sarah Bajan et al. Cells
- Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability
- (2020) Ander Maguregui et al. CHEMBIOCHEM
- Epithelial-mesenchymal transition and membrane microparticles: Potential implications for bronchiolitis obliterans syndrome after lung transplantation
- (2020) Benjamin Renaud-Picard et al. TRANSPLANT IMMUNOLOGY
- Recent Advances of Polycationic siRNA Vectors for Cancer Therapy
- (2020) Raut Bholakant et al. BIOMACROMOLECULES
- siRNA based drug design, quality, delivery and clinical translation
- (2020) Md Abdus Subhan et al. Nanomedicine-Nanotechnology Biology and Medicine
- Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
- (2020) Milad Ashrafizadeh et al. ACS Combinatorial Science
- Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
- (2020) Milad Ashrafizadeh et al. CELLULAR SIGNALLING
- Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA
- (2019) Maria Abdul Ghafoor Raja et al. Asian Journal of Pharmaceutical Sciences
- siRNA therapeutics: a clinical reality
- (2019) Phei Er Saw et al. Science China-Life Sciences
- Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
- (2019) Walhan Alshaer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficient nanocarriers of siRNA therapeutics for cancer treatment
- (2019) Md Abdus Subhan et al. Translational Research
- A Novel Method for Controlled Gene Expression via Combined Bleomycin and Plasmid DNA Electrotransfer
- (2019) Sonam Chopra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel ribozymes: discovery, catalytic mechanisms, and the quest to understand biological function
- (2019) Christina E Weinberg et al. NUCLEIC ACIDS RESEARCH
- Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
- (2019) Fadwa Odeh et al. MOLECULES
- Tivanisiran, a novel siRNA for the treatment of dry eye disease
- (2018) Javier Moreno-Montañés et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- Connective tissue growth factor (CTGF) from basics to clinics
- (2018) Yasaman Ramazani et al. MATRIX BIOLOGY
- Liposomal Drug Delivery Systems and Anticancer Drugs
- (2018) Temidayo Olusanya et al. MOLECULES
- Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles
- (2017) Salma Abbas et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Antisense oligonucleotides: the next frontier for treatment of neurological disorders
- (2017) Carlo Rinaldi et al. Nature Reviews Neurology
- Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
- (2017) K. John Pasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- TFOS DEWS II Definition and Classification Report
- (2017) Jennifer P. Craig et al. Ocular Surface
- Chemical and structural modifications of RNAi therapeutics
- (2016) Sook Hee Ku et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
- (2016) Jinho Park et al. ADVANCED DRUG DELIVERY REVIEWS
- Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics
- (2016) Soo Hyeon Lee et al. ADVANCED DRUG DELIVERY REVIEWS
- Delivery strategies and potential targets for siRNA in major cancer types
- (2016) So Jin Lee et al. ADVANCED DRUG DELIVERY REVIEWS
- Precise and efficient siRNA design: a key point in competent gene silencing
- (2016) E Fakhr et al. CANCER GENE THERAPY
- ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients
- (2016) Jens Gottlieb et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors
- (2016) Adeel Masood Butt et al. MOLECULAR PHARMACEUTICS
- Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
- (2016) Jake Dunning et al. PLOS MEDICINE
- siRNAmod: A database of experimentally validated chemically modified siRNAs
- (2016) Showkat Ahmad Dar et al. Scientific Reports
- Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms
- (2015) Laura Novellasdemunt et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Who discovered messenger RNA?
- (2015) Matthew Cobb CURRENT BIOLOGY
- Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis
- (2015) Julian D Gillmore et al. Orphanet Journal of Rare Diseases
- RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
- (2015) Talia Golan et al. Oncotarget
- siRNA Versus miRNA as Therapeutics for Gene Silencing
- (2015) Jenny K W Lam et al. Molecular Therapy-Nucleic Acids
- First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors
- (2014) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- Current issues of RNAi therapeutics delivery and development
- (2014) D. Haussecker JOURNAL OF CONTROLLED RELEASE
- Recent developments in the co-delivery of siRNA and small molecule anticancer drugs for cancer treatment
- (2014) Manju Saraswathy et al. Materials Today
- Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
- (2014) Y Aye et al. ONCOGENE
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Getting Syk: spleen tyrosine kinase as a therapeutic target
- (2014) Robert L. Geahlen TRENDS IN PHARMACOLOGICAL SCIENCES
- 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity
- (2014) Sherry Y. Wu et al. Nature Communications
- Complement disorders and hemolytic uremic syndrome
- (2013) Catherine Joseph et al. CURRENT OPINION IN PEDIATRICS
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease
- (2012) S. K. Brode et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- Bronchiolitis Obliterans Syndrome
- (2011) Jamie L. Todd et al. CHEST
- Therapeutic plasmid DNA versus siRNA delivery: Common and different tasks for synthetic carriers
- (2011) Claudia Scholz et al. JOURNAL OF CONTROLLED RELEASE
- Unknown
- (2011) Gerd Gauglitz et al. MOLECULAR MEDICINE
- Hepatitis B prevention, diagnosis, treatment and care: a review
- (2011) E. J. Aspinall et al. OCCUPATIONAL MEDICINE-OXFORD
- Respiratory Viral Infections in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
- (2011) S. Weigt et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027
- (2010) Peter K. Kaiser et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke–induced pulmonary injury and emphysema
- (2010) Toshinori Yoshida et al. NATURE MEDICINE
- Lipid-based systemic delivery of siRNA
- (2009) Yu-Cheng Tseng et al. ADVANCED DRUG DELIVERY REVIEWS
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder
- (2009) Sancy A Leachman et al. MOLECULAR THERAPY
- Familial adenomatous polyposis
- (2009) Elizabeth Half et al. Orphanet Journal of Rare Diseases
- Age-Related Macular Degeneration
- (2008) Rama D. Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started